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High performance liquid chromatographyOxidized phospholipid species are important, biologically relevant, lipid signaling molecules that usually
exist in low abundance in biological tissues. Along with their inherent stability issues, these oxidized
lipids present themselves as a challenge in their detection and identiﬁcation. Often times, oxidized
lipid species can co-chromatograph with non-oxidized species making the detection of the former ex-
tremely difﬁcult, even with the use of mass spectrometry. In this study, a normal-phase and reverse-
phase two dimensional high performance liquid chromatography (HPLC)–mass spectrometric system
was applied to separate oxidized phospholipids from their non-oxidized counterparts, allowing unambig-
uous detection in a total lipid extract. We have utilized bovine heart cardiolipin as well as commercially
available tetralinoleoyl cardiolipin oxidized with cytochrome c (cyt c) and hydrogen peroxide as well as
with lipoxygenase to test the separation power of the system. Our ﬁndings indicate that oxidized species
of not only cardiolipin, but other phospholipid species, can be effectively separated from their non-
oxidized counterparts in this two dimensional system. We utilized three types of biological tissues and
oxidative insults, namely rotenone treatment of lymphocytes to induce mitochondrial damage and cell
death, pulmonary inhalation exposure to single walled carbon nanotubes, as well as total body irradia-
tion, in order to identify cardiolipin oxidation products, critical to the cell damage/cell death pathways
in these tissues following cellular stress/injury. Our results indicate that selective cardiolipin (CL) oxida-
tion is a result of a non-random free radical process. In addition, we assessed the ability of the system to
identify CL oxidation products in the brain, a tissue known for its extreme complexity and diversity of CL
species. The ability of the two dimensional HPLC–mass spectrometric system to detect and characterize
oxidized lipid products will allow new studies to be formulated to probe the answers to biologically im-
portant questions with regard to oxidative lipidomics and cellular insult. This article is part of a Special
Issue entitled: Oxidized phospholipids — their properties and interactions with proteins.
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Oxidation of phospholipids and accumulation of their oxygenated
intermediates have long been considered as participants of two possi-
bly interrelated processes: cell/tissue damage and danger signaling
[1]. However, direct experimental evidence supporting these views
is scarce, mostly due to technological difﬁculties in quantitative as-
sessments of peroxidized phospholipids. The traditional point of
view is that oxidative stress causes – through yet to be identiﬁed
mechanisms – random free radical peroxidation of phospholipids
whereby the rule of preferable oxidation of most polyunsaturated
fatty acids dominates over the types of phospholipids based on the
speciﬁcity of their polar head-groups. In contrast, peroxidation
pathways catalyzed by speciﬁc catalysts – such as cytochrome c in
apoptotic cells – should non-randomly oxidize those classes of phos-
pholipids that are localized in the immediate proximity to the
catalytic sites. Among those of particular interest in the context of
peroxidation reactions are cardiolipins (CLs), a critical phospholipid
component of cellular membranes from bacteria to mammals. In bac-
teria, CL is localized in the plasma membrane while in mammals, CL is
exclusively conﬁned to the inner membrane of mitochondria [2].
While bacterial CL species are mostly saturated or monounsaturated
[2], mammalian CLs contain polyunsaturated fatty acid residues,
hence are highly prone to oxidation [3–5]. The importance of CL per-
oxidation in mammals is also emphasized by its critical role in the
function of numerous mitochondrial enzymes involved in electron
transport chain function and other proteins involved in energetic me-
tabolism which include cytochrome c (cyt c) oxidase [6], creatine ki-
nase [7], ATP synthase [8] and the mitochondrial ADP carrier [9]
among others.
Our laboratory has pioneered the work describing the speciﬁc ox-
idation of CL which is catalyzed by cyt c that acts as a CL-speciﬁc per-
oxidase in mitochondria during the early part of the apoptotic
program. Speciﬁcally, we have demonstrated that CL oxidation is re-
quired for the release of cyt c and other pro-apoptotic factors into
the cytosol and it is an important step in the mitochondrial stage of
apoptosis [10]. Since CL is sequestered primarily in mitochondria of
mammalian cells, it has also been viewed as a potent “danger signal”
to the immune system when tissue damage occurs as evidenced by
the presence of anti-CL antibodies in plasma of patients with a variety
of diseases [11–15] and the report of CL binding to the CD1 protein
and stimulating a host T-cell response to bacterial lipids and poten-
tially host CL [16]. These results suggest that the CL-responsive T
cells may play a role in immune surveillance during infection and tis-
sue injury. The fact that CL is a normal component of plasma lipopro-
teins [17], suggests that the anti-phospholipid antibodies present in
various disease states, could recognize CL or oxidized CL in conjunc-
tion with lipoproteins and/or plasma proteins. In addition, CL has
been implicated as a modulator of proteins like reactive protein c, act-
ing as a cofactor thereby promoting its anticoagulant activity [18].
As mentioned earlier, a high percentage of CL species that are
found in mitochondria are enriched in polyunsaturated fatty acids,
making them excellent candidates for oxidation in general, and to
cytochorme c-catalyzed peroxidation during apoptosis. A high degree
of structural variability of CL species exists depending upon the tissue
in question, ranging from a few major species in heart to over two
hundred plus species in brain. Oxidized forms of CL are now pursued
with high interest due to their role in apoptosis via the activation of
cyt c peroxidase activity and eventual loss of mitochondrial perme-
ability and asymmetry [19,20] and as potential signaling markers
that are released during cellular damage.
Analysis of oxidized lipids, especially peroxides, has become a
daunting task in mass spectrometry due to their low abundance,
chemical and thermal instability and the potential for further prop-
agation of lipid oxidation and eventual degradation. Peroxidized
lipids are very prone to oxidation and degradation by heat and thischaracteristic was indeed an early obstacle for their measurement
which was overcome by the use of derivatization protocols. Lately,
liquid chromatography-mass spectrometry (LC–MS) has become an
indispensable tool for the analysis of lipids. Separation of lipids can
be performed by normal and reverse phase chromatography and nu-
merous methods have been described. Normal phase separation is
based in adsorption and polarity of the lipids to the stationary surface
whereas in reverse-phase, hydrophobicity plays the major role. Both
techniques have their advantages and disadvantages. Normal phase
chromatography allows separation of lipid classes although both oxi-
dized and non-oxidized species may overlap and the signals for the
low abundant (oxidized) species may be suppressed. While reverse-
phase separation allows for the separation of individual molecular
species, multiple lipid classes may overlap. In the case of CL and its
oxidized products, additional difﬁculties arise due to their inherent
structural characteristics: the presence of two phosphate groups in
the head group and four fatty acyl moieties that give rise to multiple
structural combinations. Therefore, only the most abundant oxidized
species are visible when samples of CL are run under normal phase
conditions.
The combination of both normal phase and reverse phase chroma-
tography for the separation of individual lipid species for each group
was originally described by Pulfer [21] and this approach has been
utilized by several groups [22,23] although the literature in the area
of chromatographic separation and analysis of lipids and their oxida-
tion products is extensive [24–31]. Minkler and collaborators [32] re-
cently developed a solvent system that resolved individual CL species
on a reverse-phase column. This system was also shown to be appli-
cable not only for the separation of intact forms of CL but also their
oxidized species [5].
In the present work, we show the ability to separate not only ox-
idized species of CL but other classes of oxidized phospholipids ﬁrst
by separating phospholipids in a normal phase system in the ﬁrst di-
mension (1D) followed by a reverse-phase ion-pair based system for
separation in the second dimension (2D). We tested the power of this
system to separate oxidized and non-oxidized species of lipids in
three different tissues; in human lymphocytes treated with rotenone,
in murine lung tissue after inhalation of single walled carbon nano-
tubes (SWCNTs) and in gut (small intestine) tissue after total body ir-
radiation. In addition, we applied the 1D/2D LC–MS analysis on
samples from rat brain, to further test the system with a tissue con-
taining extensive and diverse species of CL. The use of this chromato-
graphic protocol allowed us to characterize individual species for
each phospholipid and when present, their oxidized species, with a
special emphasis on CL, in lipid extracts from cells and tissues sub-
jected to various insults. While the principle of non-random peroxi-
dation, speciﬁcally with regard to the preferential oxidation of CL
and PS, has been propagated in our previous work, the current work
allows for better resolution of the oxidized products and conﬁrms
that CL is one of the major substrates for the oxidative process in-
duced by a variety of cellular stresses, particularly those leading to
apoptotic cell death.
2. Materials and methods
2.1. Reagents
Chloroform (HPLC grade), bovine heart cardiolipin (BHC) and cyt c
were purchased from Sigma-Aldrich (St. Louis, MO, USA). Methanol,
triethylamine, acetic acid and water were all LC–MS grade from
Fisher, Scientiﬁc (Pittsburgh, PA, USA). Diethylenetriaminepentacetic
acid (DTPA), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES), deoxycholate and soybean lipoxygenase (LOX) were also
purchased from Fisher Scientiﬁc. Phospholipid standards including
tetralinoleoyl cardiolipin (TLCL) were purchased from Avanti Polar
Lipids (Alabaster, AL, USA).
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Cyt c was used to oxidize TLCL in the following buffer: HEPES
(20 mM) pH 7.4, (DTPA (100 µM), TLCL (50 µM) pH 7.4. Oxidation
was started after addition of cyt c (5 µM) and H2O2 (100 µM) and
the reaction mixture was incubated for 1 h at room temperature.
LOX was used for a more robust and efﬁcient oxidation of CL in
HEPES buffer (100 mM) pH 8.0, containing DTPA (0.5 mM), deoxy-
cholate (0.2%), and BHC (50 µM). A similar concentration of other
lipids (phosphatidylcholine (PC), phosphatidylethanolamine (PE)
and phosphatidylserine (PS)) was utilized for their oxidations. LOX
(15 U/ml) was added to the reaction system and incubated for 1 h
at room temperature. Samples were vortexed every 15 min to allow
oxygenation of the solution to occur.
2.3. Lipid extraction
Lipid extraction was performed according to the Folch procedure
described previously [33]. Brieﬂy, choloroform:methanol (2:1) was
added to the sample that was resuspended in KCl (0.75%) in a ratio
5/1. The sample was kept on ice for 1 h with vortexing every
15 min. The organic layer was removed and ﬁltered with Whatman
number 4 ﬁlter paper (Whatman, Inc., Piscataway, NJ) and dried
over nitrogen. Samples were resuspended in the appropriate 1D or
2D solvent system.
2.4. 1D separation of phospholipid species and LC–MS/MS analysis
Separation of individual phospholipid classes was accomplished
by normal phase chromatography using a silica column (Luna, 3 μm,
15 cm×2 mm i.d. or a Luna 5 μm, 25 cm×2 mm i.d., Phenomenex,
Inc., Torrance, CA). Phospholipids were eluted from the column using
the following solvent system: Solvent A: chloroform:methanol:triethy-
lamine:acetic acid, (80:19:0.5:0.5); Solvent B: chloroform:methanol:
water:triethylamine:acetic acid, (60:33.5:5.5:1:0.065). Flow was main-
tained at 0.2 ml/min and a linear gradient of 0–100% B in 30 min was
run (15 cm column). Alternatively, the following gradient system was
utilized: 0–6 min 100% A; 6–40 min 100% B; 40–50 min 100% B;
50–55 min 100% A; 55–70 min 100% A (25 cm column, 0.3 ml/min).
Separation was performed at room temperature.
Fifty to eighty percent of the ﬂow was diverted to a fraction col-
lector while the remainder was utilized for MS analysis. Chromato-
graphic systems included either a Hewlett Packard 1050 liquid
chromatograph (Hewlett Packard, Inc., Palo Alto, CA) or a Shimadzu
Prominence HPLC system (Shimadzu, Inc., Kyoto, Japan). Spectra
were analyzed either on a T7000 triple quadrupole mass spectrome-
ter (ThermoElectron, Inc. San Jose, CA) or on a Waters Q-TOF mass
spectrometer (Waters, Inc., Milford, MA). Parameters for the T7000
were as follows: spray voltage, 5.0 kV, negative mode; capillary,
250 °C; sheath gas, 20 psi. Spectra were collected in a data dependent
mode. Tuning and collision energies were optimized for individual
phospholipid classes. Parameters for the Q-TOF were as follows: cap-
illary voltage, 2.85 kV, negative mode; source temperature, 100 °C;
desolvation gas, 400 L/h; sampling cone, 60 V; extraction cone:
4.5 V; ion guide, 3.0 V. Tuning was optimized for all lipids across the
scan range.
2.5. 2D separation of phospholipid species and LC–MS/MS analysis
Fractions corresponding to individual phospholipid classes were
collected from the 1D separation, combined and dried over nitrogen.
The lipids were dissolved in the appropriate 2D solvent (see later)
and were subsequently analyzed in a second dimension system. For
CL, either a C8 column (5 μm, 4.6 mm×15 cm, Phenomenex, Inc.) or
a C18 column (5 μm, 4.6 mm×15 cm, Phenomenex, Inc.) was usedwith either an isocratic solvent system consisting of 2-propanol:
water: triethylamine: acetic acid (45:5:0.25:0.25) or with a gradient
solvent system consisting of acetonitrile: water: triethylamine: acetic
acid (45:5:0.25:0.25, solvent A) and 2-propanol: water: triethylamine:
acetic acid (45:5:0.25:0.25, solvent B). The gradient programwas as fol-
lows: 0–5 min 50% B; 5–10 min 65% B; 10–25 min 75% B; 25–45 min
95% B; 45–50 min 95% B; 50–55min 50% B and 55–60 min 50% B for
re-equilibration. Flow was maintained at 0.4 ml/min and analysis was
performed on aWaters Premier Q-TOFmass spectrometer. The remain-
ing phospholipids were analyzed on an ion trap mass spectrometer
(LCQ-Duo, ThermoElectron, Inc.) using a C18 column (Luna, 5 μm,
4.6 mm×15 cm, Phenomenex, Inc.) with a gradient that was modiﬁed
from a previously described solvent system [5] and was as follows:
0–5 min 50% B, 5–15 min 80% B, 15–30 min 100% B, 30–45min 100%
B, 45–50 min 50% B, 50–55 min 50% B for re-equilibration of the column
using a Spectra 6000 solvent delivery system (Thermo-Electron, Inc.).
Flow was maintained at 0.4 ml/min. In some experiments, data was
collected in a data dependent mode in which both MS and MS/MS
acquisitions were performed sequentially on the most abundant mass
ions. Instrument conditions for the Waters Premier Q-TOF mass spec-
trometer were as follows: capillary voltage, 2.85 kV, negative mode;
source temperature, 100 °C; desolvation gas, 400 L/h; sampling cone,
60 V; extraction cone: 4.5 V; ion guide, 3.0 V. Tuning was optimized
for all lipids across the scan range. Instrument conditions for the ion
trap analysis were as follows: capillary temperature, 250 °C; spray volt-
age, 4.5 kV; sheath gas, 30 psi. All other tuning parameters were opti-
mized for each individual lipid class. All of the aforementioned
separations were performed at room temperature. Alternatively, using
a smaller dimension C18 column (1.0 mm×15 cm, 3 μm Luna 2 reverse
phase, Phenomenex, Inc.), a modiﬁed solvent system was used which
consisted of solvent A: acetonitrile: water: triethylamine:acetic acid
(45:5:0.25:0.25) containing 0.01% formic acid and 5 mM ammonium
acetate and solvent B: 2-propanol:water:triethylamine:acetic acid
(45:5:0.25:0.25) containing 0.01% formic acid and 5 mM ammonium
acetate. Column temperature was 30 °C and ﬂow was maintained at
55 µl/min on a Dionex Ultimate 3000 HPLC system (Thermo, Inc.).
Spectra were acquired on a Thermo LXQ ion trap mass spectrometer
(Thermo, Inc.) using a spray voltage of 5.0 kV and a capillary tempera-
ture of 150 °C. Scans were collected in a data dependent mode with
an isolation width of 1.5 Da and a normalized collision energy of 30 V.
The HPLC gradient was as follows: 0–5 min 50% B; 5–10 min 75% B;
10–25 min 85% B; 25–40 min 95% B; 40–50 min 95% B; 50–60 min
50% B and 60–70 min 50% B.
2.6. Treatment of lymphocytes with rotenone
Human peripheral blood lymphocytes were isolated from whole
blood with the use of Histopaque (Sigma-Aldrich, St. Louis, MO,
USA) according to the manufacturer's instructions. Monocytes were
removed by their characteristic adherence to plastic (1 h, 37 °C).
The non-adherent cells (human lymphocytes) were washed with
PBS and incubated with rotenone (250 µM) for 18 h at 37 °C. Cells
were harvested and lipids were extracted according to the protocol
described earlier.
2.7. Particles and exposure of mice to SWCNTs
SWCNTs were purchased from Carbon Nanotechnology (CNI,
Houston, TX). The nanotubes were manufactured using the high-
pressure CO disproportionation process (HiPco) and were used in
the inhalation studies. The supplied SWCNTs contained nanometer-
scale Fe catalyst particles inherent in the HiPco process. Analysis indi-
cates that these SWCNTs contained elemental carbon (82% wt), Fe
(17.7%). Trace elements present included Cu (0.16%), Cr (0.049%),
and Ni (0.046%). C57BL/6 mice were exposed to SWCNTs via inhalation
(5 mg/m3, whole body inhalation for 4 consecutive days, 5 h/day) [34].
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Fig. 1. First dimension (1D) separation of rat brain phospholipids by normal-phase
HPLC–MS/MS. Lipids were extracted from rat brain tissue (non-mitochondrial
enriched) andwere subjected to 1D LC–MS analysis on a normal phase column. Individ-
ual lipid classes were identiﬁed based on retention times and MS/MS analyses. Major
phospholipid and glycolipid fractions eluted in the following order; ceramide/
glycolipids, PG, CL, PI, PE, PS, PC/PA, SM as indicated. A base peak intensity plot is shown.
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Committee and the Institutional Animal Care and Use Committee of
the University of Pittsburgh.
2.8. Isolation of crude mitochondrial/synaptosomal (P2) fraction from rat
brain tissue
Rats were perfused transcardially with ice-cold saline and then
decapitated. Brains (minus cerebellum) were rapidly removed and885
12 16 20 240
100
909905887857883
PI
0
100
R
el
at
iv
e 
Ab
u
n
da
nc
e 
(%
)
17 21 25
747
769
749
PG
100
18 22 26 30
0
789
967 871787 817
SM
A
1448
Time (min)
16 19 22 25
0
100
CL
1398
1450
1452
Fig. 2. Second dimension (2D) separation of rat brain phospholipids by reverse-phase HPLC–
ysis were pooled based on phospholipid class and re-chromatographed in the 2D C18 reverse
following rat brain phospholipid classes which eluted as essentially single peaks in the 1D s
6), (PG, 3), (SM, 5) and (CL, 4), A. Chromatograms for PI, PG and SM. The chromatogram for C
class are shown in B.ipsilateral pericontusional cortex was isolated and placed in ten vol-
umes of ice-cold 0.32 M sucrose in 1 mM Tris buffer (pH 7.4). The tis-
sue was homogenized in a Teﬂon/glass homogenizer by ten gentle
strokes. The homogenate was spun at 1000 g for 10 min to remove
nuclei and cell debris. The resulting supernatant was centrifuged at
10,000 g for 20 min to obtain the crude mitochondrial pellet. The pel-
let was washed and centrifuged (4 min, 10,000 g at 4 °C).2.9. Total body irradiation
Groups of C57BL/6NHsd female mice were irradiated to a dose of
9.5 Gy of total body irradiation using a Shepherd Mark 1 Model 68 ce-
sium irradiator at a dose rate of 80 cGy/min as previously described
[35]. The mice were sacriﬁced at 5 days post irradiation by CO2 inha-
lation. A 5-cm piece of small intestine was removed, cut open, washed
in PBS to remove fecal material, blotted dry and frozen in liquid nitro-
gen. All procedures were pre-approved and performed according to
protocols established by the Institutional Animal Care and Use Com-
mittee of the University of Pittsburgh.3. Results
3.1. First dimension separation of phospholipids
A total lipid extract from murine brain was separated by LC–MS
using a normal phase column in the ﬁrst dimension. Excellent separa-
tion of phospholipid classes resulted as shown in Fig. 1. Ceramides
and glycolipids eluted within the ﬁrst 4 min of the gradient. This
was followed by phosphatidylglycerol (PG), CL, phosphatidylinositol
(PI), PE, PS, PC and sphingomyelin (SM). In this particular proﬁle, a
1:1 split of the column efﬂuent was performed, diverting half of the
ﬂow to a fraction collector and the remaining half to the mass spec-
trometer. Fractions containing individual phospholipid classes were
pooled, dried over nitrogen and dissolved in appropriate running sol-
vent for chromatography in the second dimension.840 880 920 960
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Individual classes of phospholipids from the ﬁrst dimension chro-
matography were re-chromatographed on a reversed-phase C18 col-
umn for the second dimension analysis. Fig. 2A displays the power of
the second dimension system where PI, PG, SM and CL, which eluted
as one peak in the ﬁrst dimension, were resolved into multiple peaks
in the second dimension. The dominant peak for PI (m/z 885, Fig. 2B)
eluting at 19.1 min had a fatty acyl chain composition of 18:0/20:4
upon MS/MS analysis. The dominant peak for PG eluting at 20.6 min
was identiﬁed as a 16:0/18:1 PG (m/z 747, Fig. 2B). The dominant
SM species in brain (m/z 789, Fig. 2B) was identiﬁed as a d18:0/
18:1 SM which eluted as an acetate adduct. In contrast, while some
degree of species separation was obtained with brain CL (Fig. 2A),
multiple overlapping species still existed within each of the baseline
resolved peaks. A summed spectrum over all of these peaks
(Fig. 2B) still displays extreme complexity of this phospholipid in
brain tissue.
3.3. Oxidized phospholipids elute at earlier retention times in the second
dimension system
One of the goals of this work was to develop a system that
would separate oxidized phospholipid species from non-oxidizedR
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Fig. 3. Second dimension (2D) analysis of brain PC, PE and PS oxidized in the presence of li
Fractions corresponding to individual phospholipid classes were pooled, oxidized with lipo
Lipids were identiﬁed based on retention time and MS/MS analysis. In all cases, oxidized sp
A: Chromatograms for PC, PE and PS. B: Spectra from the individual 2D chromatograms for n
non-oxidized species and are as follows; PC (22–28 min), PE (22–33 min) and PS (20–32 m
summed over the retention times associated with the oxidized products and are as follows:
on the oxidized PS species (m/z 866). Fatty acyl chain analysis is shown with an oxidation o
tation scheme is shown for the main fragments indicating the loss of stearic acid (m/z 283), t
(m/z 359). The fragment at m/z 418 is a result of the loss of both the serine residue from tphospholipid species. During a 1D elution of lipids on a normal
phase column, oxidized species can co-elute with non-oxidized spe-
cies. Since oxidized species usually exist in lower abundance, these
biologically important lipids may go undetected. While this partly de-
pends upon the column chemistry chosen and the solvent system uti-
lized, our experience indicates that this is generally the case. In order
to determine whether or not the 1D/2D system would meet these re-
quirements, we tested the system by pooling individual phospholipid
species of PC, PE and PS from the one dimensional run and oxidizing
them in the presence of LOX as indicated in the Materials and
methods section. As shown in Fig. 3A, oxidized species of PC, PE and
PS eluted earlier (within the ﬁrst 20 min retention time window)
than their non-oxidized counterparts eluting after 20 min. These re-
sults are in agreement with an increased hydrophilic character of
the oxidized species which should decrease their retention time in a
reverse-phase system. Fig. 3B indicates the major non-oxidized
masses of brain PC, PE and PS. Major species of PC included 16:0/
16:0 PC, acetate adduct (m/z 792) and 16:0/18:1 PC, acetate adduct
(m/z 818). Additional major species of PE and PS are also noted.
Some of the major oxidized species of PE, PC and PS (Fig. 3C) that
were summed over the ﬁrst 20 min retention time window and
eluted earlier than their non-oxidized species included m/z 822
(PE 18:0/22:6+OO), m/z 900 (PC 20:5+O/22:6+OO) and m/z 866
(PS 18:0/22:6+OO), respectively. Oxidations were conﬁrmed by760 800 840 8800
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poxygenase. A total rat brain lipid extract was chromatographed in the 1st dimension.
xygenase and chromatographed in the second dimension system using a C18 column.
ecies eluted at earlier retention times as compared to their non-oxidized counterparts.
on-oxidized PC, PE and PS were summed over the retention times associated with the
in). C: Spectra from the individual 2D chromatograms for oxidized PC, PE and PS were
PC (10–18 min), PE (6–20 min) and PS (6–18 min). D: MS/MS analysis was performed
f a 22:6 fatty acid chain (m/z 359) indicating the addition of two oxygens. A fragmen-
he loss of the serine residue (m/z 779) as well as the loss of the oxidized fatty acid chain
he head group and the oxidized fatty acid chain.
2418 A.K. Samhan-Arias et al. / Biochimica et Biophysica Acta 1818 (2012) 2413–2423MS/MS analysis. One example is shown in Fig. 3D where MS/MS
analysis of PS (m/z 866) indicated a fatty acyl composition of 18:0/
22:6+OO, indicating a +32 Da increase in the 22:6 fatty acyl chain
(m/z 359) which normally exhibits a mass at 327 Da. A fragmentation
scheme is shown for the main fragments indicating the loss of stearic
acid (m/z 283), the loss of the serine from the head group (m/z 779)
as well as the loss of the oxidized fatty acid chain (m/z 359). The
fragment at m/z 418 is a result of the loss of both the serine residue
from the head group and the oxidized fatty acid chain. The species
at m/z 761 indicates a loss of water.
3.4. Retention time of oxidized species of bovine heart cardiolipin (BHC)
and TLCL in a 1D/2D separation system is dependent on the degree of
oxidation
To further test the 1D/2D separation system, we oxidized TLCL as
indicated in the Materials and methods section. As in the case with
other phospholipid species tested, oxidized species of TLCL exhibited
earlier retention times (Fig. 4A), this being dependent on the degree
of oxidation. Commercially available TLCL contains tetralinoleoyl CL
(m/z 1448) as its dominant CL species, with a minor sodiated species
at m/z 1470 (Fig. 4B). Oxidation can be induced in the presence of cyt
c and H2O2, as well as in the presence of LOX (Fig. 4B,C). The main ox-
idized products when cyt c was used consisted of hydroperoxy (m/z
1480) TLCL. A small amount of mono-hydroxy TLCL (m/z 1464,
Fig. 4B) existed as well as two minor species consisting of hydroxy/
hydroperoxy (m/z 1496) and di-hydroperoxy (m/z 1512) TLCL spe-
cies (Fig. 4B). All of the oxidized species eluted between 3 and
11 min, well separated from the non-oxidized TLCL species eluting
at 16 min on a C18 reversed-phase column using an isocratic solventC
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Fig. 4. Treatment of TLCL and BHC with cyt c/H2O2 and LOX induces products with varying d
methods and chromatographed on the 2D system on a C18 column (isocratic, 100% sovent
either with cyt c/H2O2 or with LOX as described in Materials and methods. Oxidation with
hydroxy (m/z 1464), mono-peroxy/hydroxy (m/z 1496) and di-hydroperoxy (m/z 1512) spe
of highly oxidized TLCL, one of which contained a combination of peroxy/hydroxy modiﬁc
products of BHC and TLCL eluted at earlier retention times (3–11 min) than their non-oxidize
after treatment with cyt c/H2O2 or LOX. Major oxidized products resulting from treatmentsystem of 100% solvent B. On the other hand, oxidation with LOX, a
more robust oxidizing system, produced a shift in the chromatogram
(Fig. 4C) to a more highly oxidized, earlier eluting species with a m/z
of 1576 (Fig. 4B) which consisted of TLCL with a combination of
hydroperoxy and hydroxy modiﬁcations (+128 Da increase).
Similar results were obtained when BHC was used as a substrate.
Second dimension separation of oxidized from non-oxidized CL spe-
cies indicated oxidized products eluting earlier (Fig. 4C), which con-
sisted of mono-hydroxy and mono-hydroperoxy BHC (m/z 1464 and
1480, respectively, Fig. 4D) as the major species when cyt c was
used (Fig. 4D). Oxidation with LOX produced a chromatogram con-
sisting of highly oxidized species (Fig. 4C), with the major peak elut-
ing at 3.5 min. This peak contained a main species at m/z 1576
(Fig. 4D) which consisted of BHC with a mixture of peroxy and hy-
droxy modiﬁcations. These results indicated that the 1D/2D system
is capable of separating oxidized species of CL from non-oxidized spe-
cies. In addition, these results also indicated that the 1D/2D system
could then make the detection of low abundant oxidized CL species
possible.
3.5. Treatment of lymphocytes with rotenone induces oxidation of cardio-
lipin that is detectable after 1D/2D LC–MS analysis
We next tested the 1D/2D system for its ability to detect oxidized
species of CL after treatment of lymphocytes with the pesticide, rote-
none. Rotenone inhibits electron transport chain function by interfer-
ing with the transfer of electrons from the iron-sulfur centers in
complex I to ubiquinone producing an increase in reactive oxygen
species (ROS) production. This mimics the mitochondrial death path-
way via mitochondrial dysfunction seen in many disease states. ForD
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2419A.K. Samhan-Arias et al. / Biochimica et Biophysica Acta 1818 (2012) 2413–2423these studies, human lymphocytes were treated with 250 μM of rote-
none for 18 h. Lipids were extracted and separated in a 1D system as
described in Materials and methods. A total of 91 lipid species were
identiﬁed between the ﬁrst and second dimension analyses. The CL
fractions from the ﬁrst dimension were isolated, pooled and re-
chromatographed in the second dimension utilizing, in this case, a
C8 column using a isocratic solvent system of 100% solvent B. We hy-
pothesized that the oxidized species would be in low abundance in
this biological system. We reasoned that utilization of a C8 reverse-
phase column would allow better concentration of oxidized species
thereby producing a higher signal to noise ratio. This results in the
elution of CL-ox species in the 4–6 min retention time window
and the CL species in the 6–8 min retention time window. The CL spe-
cies from lymphocytes eluted at 6.4 min in the second dimension
(Fig. 5A). Our results indicated that human lymphocytes contained0
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Fig. 6. Inhalation of SWCNT's induces CL oxidation. Murine lung tissue was harvested on day
analyzed on the 1D/2D LC–MS system (C8 column, 100% solvent B). A: non-oxidized CL spect
retention time window (4–6 min), were noted. Elemental compositions for CL masses are as
1475.9931, C83H145O17P2; 1497.9871, C85H143O17P2; 1519.9675, C87H141O17P2.TLCL (m/z 1448) as their major CL species (Fig. 5B), although 11 spe-
cies were identiﬁed. Treatment with rotenone induced oxidation of
CL, with two major species appearing at m/z 1464 (mono-hydroxy)
andm/z 1480 (mono-hydroperoxy/or di-hydroxy, Fig. 5C). These spe-
cies, although in low abundance, eluted between 4 and 5.5 min in the
2D system. Minor species indicating higher degrees of oxidation were
also detected. As expected, these species were undetectable in the
ﬁrst dimension (not shown), due to the ion suppression produced
by the more highly abundant non-oxidized CL species. These results
indicated that the 1D/2D system was capable of detecting oxidized
CL species from a biological model system. Interestingly, the effect
of rotenone on lipid oxidation appeared to be speciﬁc for CL as no
other oxidized lipids were detected in the 1D/2D system. This most
likely reﬂects the speciﬁcity of rotenone as a mitochondrial complex
I inhibitor.1476
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7 after four days of SWCNT exposure (5 h/day). Lung tissue was extracted for lipids and
rum. B: Increases in CL-ox species (m/z 1480, 1502 and 1508, which eluted in the CL-ox
follows: 1395.9331, C77H137O17P2; 1423.9635, C79H141O17P2; 1447.9660, C81H141O17P2;
2420 A.K. Samhan-Arias et al. / Biochimica et Biophysica Acta 1818 (2012) 2413–24233.6. Exposure to SWCNTs induces oxidation of cardiolipin in murine lung
tissue as detected by the 1D/2D LC/MS system
Mice exposed to SWCNTs via inhalation were sacriﬁced on day 7.
Lung tissue was harvested and extracted for lipids. CL was isolated in
the ﬁrst dimension and analyzed in the second dimension using the
protocol described in this study. Using this protocol, we were able
to resolve non-oxidized from oxidized species of CL that differed sig-
niﬁcantly in their retention times. The non-oxidized CL proﬁle from
lung is shown in Fig. 6A. Species at m/z 1448, 1470 and 1476 have
been previously identiﬁed as CLs with the following fatty acyl composi-
tion: C18:2/C18:2/C18:2/C18:2, C18:2/C18:2/C18:2/C18:2+sodium and C18:2/
C18:1/C18:1/C20:4, respectively [35]. Both control and SWCNT samples
displayed similar chromatographic proﬁles with non-oxidized CL
eluting at 6.5 min and oxidized CL species eluting within the
4–6 min retention time window on the C8 column, again using an
isocratic solvent system of 100% solvent B (not shown). Summation
of spectra within this oxidized region indicated the presence of char-
acteristic species of oxidized CL at m/z values of 1480, 1502 and 1508
at approximately a 3-fold higher intensity for the SWCNT exposed
sample (SWCNT treatment, day 7) as compared to control (control,
Fig. 6B). Controls displayed only minor amounts of m/z species
1480 and 1502. These oxidized species at m/z 1480, 1502 and 1508
were generated from the non-oxidized CL species at m/z 1448,20 32 44
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Fig. 7. Second dimension (2D) analysis of CL from irradiated murine small intestine. Mice
intestine tissue and were subjected to 1D LC–MS analysis on a normal phase column. The CL
(full gradient). A: The base peak chromatogram indicated a separation of non-oxidized CL sp
is also shown for the non-oxidized CL. B: 2D analysis of CL from irradiated small intestine. B
spectrum from the oxidized region (22–27 min retention time window, inset). C: LC–MS/M
and b respectively). A fragmentation scheme is shown earlier for the main fragments of m/z
oxidized phosphatidic acid (PA) structure (m/z 727), one non-oxidized PA structure (m/z 6
earlier for the main fragments of m/z 1464 (C, b) indicating the loss of hydroxy-linoleic ac
structure (m/z 711 and 695, respectively). The fragment at m/z 415 indicates m/z 695 min1470 and 1476 with +32 Da increases reﬂecting mono-peroxy or
di-hydroxy additions.
3.7. Whole body irradiation induces oxidation of CL in murine gut tissue
as detected by the 1D/2D LC–MS system
Mice receiving 9.5 Gy of whole body irradiation were sacriﬁced
5 days post-irradiation. Small intestine tissue was harvested as de-
scribed in Materials and methods and processed for lipid extraction.
CL was isolated in the ﬁrst dimension (not shown) and analyzed in
the second dimension utilizing the modiﬁed HPLC solvent system
containing formic acid and ammonium acetate on the 1.0 mm C18
column described in Materials and methods. The method utilizing
this particular column and solvent system utilized a ﬂow rate of
55 µl/min, thus adding to the extended retention times for CL and
CL-ox products. The small intestine non-oxidized CL for the irradiated
sample eluted in a series of peaks in the reverse-phase system over a
retention time of 30–40 min and consisted of 5–6 main CL clusters
(Fig. 7A). Summation of spectra in the CL-ox region (20–30 min re-
tention time) indicated two mass ions at m/z 1464 (25.7 min) and
1480 (23.3 min), which correlated with their base peak chromato-
grams (Fig. 7B). We compared these results from irradiated tissue to
a model system where CL was oxidized with cyt c and H2O2 as de-
scribed in Materials and methods. Indeed, oxidized CL eluted withinC
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were exposed to whole body irradiation and lipids were extracted from murine small
fraction from the 1D run was re-chromatographed in the 2D on a 1.0 mm C18 column
ecies which eluted within the 30–40 min retention time window. A summed spectrum
ase peak chromatograms for m/z 1464 and m/z 1480 are shown along with a summed
S analysis of m/z 1480 and m/z 1464 species from TLCL oxidized with cyt c/H2O2. (C, a
1480 (C, a) indicating the loss of the oxidized fatty acyl chain (m/z 311), the loss of one
95) as well as the loss of linoleic acid (m/z 279). A fragmentation scheme is also shown
id (m/z 295), linoleic acid (m/z 279) as well as one oxidized and one nonoxidized PA
us linoleic acid.
2421A.K. Samhan-Arias et al. / Biochimica et Biophysica Acta 1818 (2012) 2413–2423the 20–30 min retention time window with corresponding mass ions
at m/z 1464 and 1480 (not shown). When we compared fragmenta-
tion patterns of mass ions with m/z 1480 and 1464 from our model
system to the same mass ions seen in the irradiated small intestine
sample, similar fragmentation patterns were seen. The m/z 1480 ion
from the irradiated tissue displayed linoleic acid as one of the fatty
acyl chains (m/z 279) as well as fragment ions at m/z 695 and 727,
all which are seen in the TLCL sample oxidized with cyt c/H2O2
(Fig. 7C,a), indicating that oxidation had occurred as determined by
the +32 Da mass increase. A fragmentation scheme is shown earlier
for the main fragments indicating the loss of the oxidized fatty acyl
chain (m/z 311), the loss of one oxidized phosphatidic acid (PA)
structure (m/z 727) and one non-oxidized PA structure (m/z 695)
as well as the loss of linoleic acid (m/z 279). In addition, the daughter
ion spectrum of the m/z 1464 mass ion from the irradiated tissue also
displayed the same fragments at m/z 695 and 711 indicating a
+16 Da mass increase, analogous to the TLCL sample oxidized with
cyt c/H2O 2 containing one linoleic (m/z 279) and one hydroxy lino-
leic fatty acyl chain (m/z 295, Fig. 7 C,b). A fragmentation scheme is
also shown earlier for the main fragments indicating the loss of
hydroxy-linoleic acid (m/z 295), linoleic acid (m/z 279) as well as
one oxidized and one nonoxidized PA structure (m/z 711 and 695, re-
spectively). The fragment at m/z 415 indicates m/z 695 minus linoleic
acid. Thus, it was concluded that the CL species at m/z 1464 and 1480
in the irradiated tissue was oxidized as determined from their respec-
tive retention times and fragmentation patterns.
3.8. Evidence for CL oxidation in normal rat brain tissue
We next determined whether the 1D/2D LC–MS system could be
applied to normal brain tissue, where the complexity and diversity
of CL species is apparent. Crude mitochondrial fractions were isolated
from rat brain tissue and lipids were extracted. CL was isolated in the
ﬁrst dimension and re-chromatographed in the second dimension
system. Fig. 8 (top panel) displays the 2D LC–MS chromatogram in
which the non-oxidized CL eluted within the 6–8 min retention
time window using a C8 column with 100% solvent B. The spectrum
for the non-oxidized CL species (Fig. 8, bottom right panel) displays
the extreme diversity of brain CL with 8 clusters of CL signals within
the m/z 1340 to 1540 range. Also seen in the normal brain was a
small amount of CL-ox species, which eluted within the 4–6 min2 4
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Fig. 8. Assessment of oxidized CL species in normal rat brain tissue. Lipids were extracted fr
lected and re-chromatographed in the 2D system (C8 column, 100% solvent B). Top panel: T
right panel: Representative spectrum for non-oxidized brain CL. Bottom left panel: Repres
follows: 1345.9111, C73H135O17P2; 1373.9478, C75H139O17P2; 1399.9681, C77H141O17P2; 142
C85H145O17P2; 1523.9994, C87H145O17P2.retention time window (Fig. 8 bottom left panel). Interestingly,
these species fell within a m/z range of 1540 to 1680. While these
species were in too low abundance for structural identiﬁcation, pre-
liminary experiments with an in vitro model system (not shown) in-
dicated that one of the major species (m/z 1552) suggested the
presence of two linoleic chains with hydroxy/peroxy modiﬁcations
(+48 Da per chain). It should be noted here that tissue homogeniza-
tion can, in some cases, be a potential causative agent for oxidation.
However, this is usually associated with excessive handling/homoge-
nization of tissue which was not the case in these studies. Here, a
glass Dounce homogenizer was used to deliver only ten gentle strokes
for tissue disruption. Oxidation induced by homogenization would
have undoubtedly resulted in the accumulation of peroxidation prod-
ucts in most of the polyunsaturated lipids, which was not the case in
these studies. These results suggest that CL oxidation products can be
assessed in tissues such as brain, containing a high degree of CL com-
plexity and diversity. In addition, signiﬁcantly elevated levels of CL-ox
have been observed after traumatic brain injury (Ji, et al., submitted),
[36], lending support to the non-random and speciﬁc, rather than
non-speciﬁc, character of the oxidative process.4. Discussion
Peroxidation of lipids is believed to occur through twomajor path-
ways: 1) a non-enzymatic free radical process and 2) an enzymatic re-
action process where radical intermediates are “caged” within the
regulated protein environment [37]. The two most prominent fea-
tures of non-enzymatic peroxidation are 1) its random character
with regards to the major classes of phospholipids whereby speciﬁc-
ity is driven by the degree of unsaturation of the substrates [38,39],
and 2) a plethora of different oxidation products from hydroperox-
ides to carbonyl compounds and truncated species formed as a result
of beta-scission [37]. By contrast, enzymatic peroxidation is speciﬁc
with regards to both oxidation substrates as well as reaction products.
Until recently, a detailed characterization of these most important
characteristics of peroxidation, with a notable exception of oxygen-
ated fatty acids, represented an extremely challenging and in many
cases, an almost impossible task. With the advent of mild ioniza-
tion techniques and contemporary MS protocols, these techno-
logical issues slowly ﬁnd their solutions and characterization of lipidTime (min)
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he 2D CL base peak chromatogram indicated a separation CL and CLox species. Bottom
entative spectrum for oxidized brain CL. Elemental compositions for CL masses are as
7.9907, C79H145O17P2; 1449.9856, C81H143O17P2; 1475.9945, C83H145O17P2; 1449.9953,
2422 A.K. Samhan-Arias et al. / Biochimica et Biophysica Acta 1818 (2012) 2413–2423peroxidation products in complex biological mixtures becomes a
more realistic goal.
Here, we have utilized a normal phase/reverse-phase two dimen-
sional HPLC MS/MS method for the analysis of oxidized lipid species,
especially as it applies to CL. We ﬁrst tested the 2D separation system
with CL oxidized in the presence of cyt c/H2O2 as well as with LOX.
Oxidized CL species were clearly separated from non-oxidized species
in the second dimension due to their increased hydrophilicity. In ad-
dition, elution proﬁles correlated with the degree of oxidation, with
the more highly oxidized species eluting ﬁrst. The 1D/2D system
was also tested on PC, PE and PS species isolated in the ﬁrst dimen-
sion from a total brain lipid extract. These isolated phospholipid clas-
ses were then treated with LOX to induce oxidation. The products of
the reaction were then re-chromatographed in the second dimension.
As seen in the case of CL and oxidized CL, all oxidized species of PC, PE
and PS were clearly separated from the non-oxidized species and
eluted at earlier time points on the reverse-phase system, indicating
that this system could be utilized for all phospholipid classes. Oxida-
tion of TLCL or BHC with cyt c/H2O2 produced oxidized species mainly
consisting of hydroxy and hydroperoxy species. A more robust oxida-
tion was seen when LOX was used which generated higher degrees of
oxidation across all fatty acyl chains as evidenced by the increased
mass of the oxidized products.
We further tested the system with four biologically relevant
model systems in four different tissue settings. The ﬁrst model system
involved the treatment of human lymphocytes with the pesticide ro-
tenone, an agent known to induce mitochondrial damage via complex
I and increased ROS. Our results indicated that oxidized CL species
eluted earlier and were clearly separated from non-oxidized CL spe-
cies. Two major CL oxidations occurred with rotenone treatment
and included hydroxylations and peroxidations, mainly associated
with the oxidizable linoleic fatty acyl chains. Oxidations in other
lipids were not detected most likely due to the direct effect of rote-
none on mitochondrial complex I activity, resulting in an increase in
ROS, an oxidative event which is biased toward CL. This strongly sug-
gests that in the rotenone/lymphocyte system, oxidation of CL is a
non-random event, occurring within two CL species, all containing
two or more linoleic fatty acyl chains.
Our second system involved a biologically different but relevant
SWCNT inhalation model. Here, CNT inhalation caused an enhance-
ment of two oxidized CL species at m/z 1480, 1502 (sodium adduct)
and 1508. These represented +32 Da increases from their respective
parent masses indicating di-hydroxy and/or mono-peroxy modiﬁca-
tions. Here again, oxidation appeared to be speciﬁc (biased mostly to-
ward oxidation of linoleic species) strongly suggesting a non-random
pattern of oxidation.
Our third system involved the effect of radiation on gut (small in-
testine) tissue. Here, we identiﬁed two oxidized species of CL (m/z
1464 and 1480) ﬁve days after radiation exposure. Fragmentation of
these species indicated that hydroxy (m/z 1464) and di-hydroxy/
mono-peroxy (m/z 1480) modiﬁcations were present. Linoleic fatty
acyl chains were once again identiﬁed as the target of oxidation.
The presence of oxidized species of CL was also conﬁrmed by their de-
creased and essentially identical retention times in the 2D reverse-
phase system to that of CL oxidized in the presence of cyt c/H2O2.
Finally, we were able to assess oxidized CL within normal rat brain
tissue. Oxidized CL species were detected in this tissue despite their
low abundance. Unlike lymphocyte, lung and small intestine, oxi-
dized CL species in brain appear at much higher m/z values. While
this is most likely due to the extreme diversity in CL species in this tis-
sue, the results still converge on linoleic fatty acyl chains as one of the
main targets of oxidative attack. A comparison between oxidized CL
species generated in vitro in a model system with cyt c and LOX ver-
sus those species found in rotenone-treated lymphocytes, SWCNT in-
halation, whole body irradiation and normal brain tissue indicates a
preference or bias toward the involvement of enzymatic pathwaysof oxidation over non-enzymatic pathways. The speciﬁcity and sub-
strate preference found in all four biological samples strongly implies
that non-random oxidation is the driving force behind these process-
es. In all of these cases it should be explained that the non-random
oxidation process that is referred to here are those species of CL and
PS that appear to be speciﬁcally susceptible to oxidation despite the
fact that other oxidizable phospholipids are plentiful, containing mul-
tiple double bonds in their fatty acyl chains. Still, CL and PS with
lower levels of polyunsaturated fatty acids present themselves as
the main phospholipid species that are oxidized. With respect to CL,
the number of oxidation products is directly related by the abundance
and most likely the particular species of CLs that interact with cyt c.
Structural analysis indicated that oxidations of CL containing lino-
leic fatty acyl chains were most common, which included hydroxy
and mono-peroxy/di-hydroxy modiﬁcations. While other polyunsat-
urated fatty acyl chains exist, which are all susceptible to oxidation,
it is interesting to speculate as to why the linoleic fatty acyl chain is
favored in CL. One obvious reason would be because of its higher
abundance. However, location of the particular CL species as well as
the substrate preference of the oxidative enzyme system may also
be partially responsible. It is interesting to note that other mitochon-
drial lipids, such as PG, containing linoleic fatty acyl chains, were not
oxidized as determined by this system. This suggests a speciﬁc oxida-
tive preference toward CL. However, the potential of rapid remodel-
ing for other mitochondrial lipid species containing oxidized fatty
acyl chains may also exist.
In this study, CL oxidation was noted in three different biological
systems and in four representative tissues. A plausible explanation
for these results may be that oxidized CL functions as both a signaling
molecule and as a danger signal for damaged tissue with the degree of
oxidation and the particular species oxidized playing a key role in this
regard.
While the current study represents an improvement in the analy-
sis and characterization of oxidized lipid species, progress in the area
of quantitation of these species is recognized and is still needed. Much
of the difﬁculty in this area stems from the lack of proper oxidized
phospholipid standards. The number of different phospholipid oxida-
tion products can be enormous such that the number of oxidized
standards that are needed become almost impractical to obtain. Com-
mercial standards for various oxidized phospholipids are extremely
scarce and are severely limited in scope. While in vitro oxidation of
phospholipid classes can be considered as potential sources of stan-
dards, controlling the type and extent of oxidation is difﬁcult and
there is no guarantee that these in vitro oxidations will directly
mimic those seen in a particular biological system. The authors
recognize this shortcoming with regard to quantitation of oxidized
phospholipid species and as a result, we are developing alternative
biochemical/enzymatic approaches that could potentially circumvent
the problem of quantitation of oxidized lipids species. The major in-
tent of this approach is to convert myriads of possible phospholipid
peroxidation products into a manageable number of different oxy-
genated PUFA. In this case, lipid extracts could be treated with a com-
bination of phospholipases to remove oxidized fatty acid chains
(lipoprotein phospholipase A2, secreted) and non-oxidized fatty acid
chains (secreted/cytosolic phospholipase A2). With the more readily
available oxidized fatty acid standards, the analytical/quantitative
power of the system can be improved remarkably by employment
of this approach with a total lipid extract to quantitate the total
amount of oxidation sites. The enzymatic approach could then be ap-
plied to individual phospholipid classes after 1D separation for a more
selective distinction of oxidation products. Additionally, comparison
of the levels of isoprostanes and lipid peroxidation products would
allow for the discrimination between random, non-enzymatic path-
ways and that of speciﬁc enzymatic pathways in damaged tissue.
This would allow for the development of more efﬁcient therapies
against oxidative stress related diseases.
2423A.K. Samhan-Arias et al. / Biochimica et Biophysica Acta 1818 (2012) 2413–2423With the application of the 1D/2D HPLC–MS system, a variety of
questions can now be formulated to probe the answers to a variety of
biologically important questions with regard to oxidative lipidomics.
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